ScholarIQanswers from OpenAlex

Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial

PaperCitations, authors & open-access status

Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial have?

ScholarIQcitation count

Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial has 86 citations in the OpenAlex counts ScholarIQ stores.

When was Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial published?

ScholarIQyear

Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial has 2020 year in the ScholarIQ index.

What is the open-access status of Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial?

ScholarIQoa status

Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial has hybrid oa status in the ScholarIQ index.

What is the DOI of Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial?

ScholarIQdoi

The DOI for Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial is on the source record.

What is the PMID of Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial?

ScholarIQpmid

The PMID for Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial is on the source record.

What is the OpenAlex record for Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial?

ScholarIQopenalex

The OpenAlex for Beta‐Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial